Chris Cashman, President and CEO of Protez Pharmaceuticals, stated "how will we practice medicine is we have antibiotic resistent bugs?" He's right, how will we? Have you thought about it?
I just attended this great session and found it very interesting because the panel laid out the truth - we will have problem in the near future. Having resistance to any treatment is not what anybody wants to hear but sometimes as we know, the truth is not always good. BUT in our industry's case it means potential, collaboration and a challenges which we all live for in Biotech. The overall theme of this panel is sharing and collaborating which will be key for solving this future problem.
By: Leslie Orischak
Puresyn, Inc.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment